My Cart [ 0 ]
Home > Antibodies > Anti-Human Antibodies for Flow Cytometry > Anti-Human HLA class II DR/DQ Monoclonal Antibodies for Flow Cytometry

Anti-Human HLA class II DR/DQ Monoclonal Antibodies for Flow Cytometry

beta1 domain MHC class II HLA DPB, CELIAC1, class II HLA beta chain, MHC class II HLA-DR, DP, DQ

Catalog No. Product Name Size List Price (US$) Quantity
PA007482.m2a Recombinant Anti-Human HLA class II DR/DQ Monoclonal Antibody, Mouse IgG2a Kappa (Clone: 9.3F10) 100 ug 100.00
PA007482.m2a Recombinant Anti-Human HLA class II DR/DQ Monoclonal Antibody, Mouse IgG2a Kappa (Clone: 9.3F10) 500 ug 200.00
PA007482.h1Fs Recombinant Anti-Human HLA class II DR/DQ Monoclonal Antibody, Human IgG1 Fc Silent Kappa (Clone: 9.3F10) 100 ug 100.00
PA007482.h1Fs Recombinant Anti-Human HLA class II DR/DQ Monoclonal Antibody, Human IgG1 Fc Silent Kappa (Clone: 9.3F10) 500 ug 200.00
Description

PA007482.m2a: Recombinant Anti-Human HLA class II DR/DQ Monoclonal Antibody, Mouse IgG2a Kappa (Clone: 9.3F10)

Recombinant Mouse IgG2a Monoclonal Antibody. 
Clone: 9.3F10.
Isotype: Mouse IgG2a Kappa.
Source: The anti-human HLA class II DR/DQ monoclonal antibody (clone: 9.3F10) was produced in mammalian cells.
Conjugation: Non-conjugated.
Specificity/Sensitivity: The recombinant 9.3F10 antibody specifically binds to human HLA class II DR/DQ.
Applications: Flow cytometry (FC), and Immunohistochemistry - Frozen (IHC-F). 
Form of Antibody: 0.2 uM filtered solution, pH 7.4, containing 0.09% sodium azide.
Purity: >95% by SDS-PAGE under reducing conditions.

PA007482.h1Fs: Recombinant Anti-Human HLA class II DR/DQ Monoclonal Antibody, Human IgG1 Fc Silent Kappa (Clone: 9.3F10)

Recombinant Human IgG1 Monoclonal Antibody with Fc silent mutation. 
Clone: 9.3F10.
Isotype: Human IgG1 kappa.
Source: The anti-human HLA class II DR/DQ monoclonal antibody (clone: 9.3F10) was produced in mammalian cells.
Conjugation: Non-conjugated.
Specificity/Sensitivity: The recombinant 9.3F10 antibody specifically binds to human HLA class II DR/DQ.
Applications: Flow cytometry (FC), and Immunohistochemistry - Frozen (IHC-F). 
Form of Antibody: 0.2 uM filtered solution, pH 7.4, containing 0.09% sodium azide.
Purity: >95% by SDS-PAGE under reducing conditions.

Shipping: The 9.3F10 antibody are shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 
12 months from date of receipt, 2 to 8°C as supplied. Do not freeze it.

References of anti-human HLA class II DR/DQ antibody (9.3F10):

IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases.
Hörner, S., et al. (2022). Cancers (Basel). 2022 Aug 16;14(16):3941. doi: 10.3390/cancers14163941. PMID: 36010934
The study utilized codon-optimized variable domains of humanized Apo-1, 2H7, 4G7 (anti-human CD19), and MOPC-21 antibodies for transfection into CHO cells. Bispecific antibodies combined the CD95 agonist Apo-1 with either anti-CD20 (clone 2H7) or anti-CD19 (clone 4G7) in F(ab)2 and single-chain formats. The CD19 binding affinity showed an EC50 of approximately 7.5 nM, despite 4G7’s higher affinity compared to 2H7. Flow cytometry revealed CD20 expression was 3–10-fold higher than CD19, with Raji cells expressing over 20,000 CD19 and 190,000 CD20 molecules per cell.
Tags: 4G7 antibody for flow cytometry; 4G7 monoclonal antibody

Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody.
Seidel, U. J., et al. (2016). Mol Ther. 2016 Sep 6;24(9):1634-43. doi: 10.1016/j.ymthe.2016.06.008. PMID: 27380762
The Fc-optimized CD19 antibody 4G7SDIE, a humanized version of the murine 4G7 antibody (anti-human CD19) with S239D and I332E modifications, was tested in B-lineage ALL blasts from 18 patients and 5 4G7SDIE-treated patients. The antibody was detected via indirect immunofluorescence staining and flow cytometry. 4G7SDIE enhanced antibody-dependent cellular cytotoxicity (ADCC) against leukemic blasts, showing promise for minimal residual disease (MRD) treatment due to favorable target-to-effector cell ratios.
Tags: anti-human CD19 4G7 mAb for flow cytometry; anti-human CD19 4G7 of low endotoxin

Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cells.
Kellner, C., et al. (2011). Cancer Lett. 2011 Jul 28;306(1):88-95. doi: 10.1016/j.canlet.2011.02.023. PMID: 21339041
The study utilized the 4G7 hybridoma (anti-human CD19; IgG1) and 3G8 (CD16; IgG1) to create Fab–scFv fusion proteins combining CD19-directed Fab fragments with CD19 and CD16 scFvs. CD19, a 95 kDa transmembrane glycoprotein, is a promising target for B-cell malignancy treatments due to its favorable properties. The bispecific antibodies demonstrated effective antibody-dependent cellular cytotoxicity (ADCC) against B-lymphoid tumor cells, highlighting CD19’s potential in immunotherapy.
Tags: anti-CD19 (4G7) monoclonal antibody; human CD19 antibody (clone 4G7)

Potent In vitro and In vivo Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia.
Horton, H. M., et al. (2008). Cancer Res. 2008 Oct 1;68(19):8049-57. doi: 10.1158/0008-5472.CAN-08-1265. PMID: 18829563
The study developed XmAb5574, a humanized and affinity-matured version of the mouse anti-CD19 antibody 4G7 with S239D/I332E Fc modifications. XmAb5574 and other anti-CD19 antibodies showed approximately 2-fold higher binding affinity than 4G7. In vitro, target cells opsonized with antibodies were mixed with NK cells, and LDH release was measured. In vivo, fluorescence-activated cell sorting confirmed CD19 expression and tumor cell percentages, demonstrating potent activity against lymphoma and leukemia.
Tags: anti-human CD19 4G7 in animal model; anti-human CD19 4G7 mAb for flow cytometry

For more references about anti-human HLA class II DR/DQantibody (9.3F10), please contact our scientific support team with message@sydlabs.com.

Syd Labs provides the following recombinant MHC/HLA monoclonal antibodies:
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2) Monoclonal Antibodies (Clone M1/42.3.9.8.HLK)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Db) Monoclonal Antibodies (Clone 28-14-8S)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Kb) Monoclonal Antibodies (Clone Y-3)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Kb) Monoclonal Antibodies (Clone AF6-88.5.3)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Kd, H-2Dd) Monoclonal Antibodies (Clone 34-1-2S)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Kd) Monoclonal Antibodies (Clone SF1-1.1.10)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Kk, H-2Dk) Monoclonal Antibodies (Clone 15-3-1S)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Kk, H-2Dk) Monoclonal Antibodies (Clone 16-1-2N)
In Vivo Grade Recombinant Anti-mouse MHC Class I (H-2Kk) Monoclonal Antibodies (Clone AF3-12.1.3)
In Vivo Grade Recombinant Anti-mouse MHC Class II (I-A) Monoclonal Antibodies (Clone Y-3P)
In Vivo Grade Recombinant Anti-mouse MHC Class II (I-A/I-E) Monoclonal Antibodies (Clone M5/114.15.2)
In Vivo Grade Recombinant Anti-mouse MHC Class II (I-Ak, I-Ar, I-Af, I-As, I-Ag7) Monoclonal Antibodies (Clone 10-3.6.2)
In Vivo Grade Recombinant Anti-mouse MHC Class II (I-Ek/RT1-D) Monoclonal Antibodies (Clone 14-4-4S)
In Vivo Grade Recombinant Anti-mouse MHC Class II (Beta chain) Monoclonal Antibodies (Clone KL277)
In Vivo Grade Recombinant Anti-human HLA-ABC Monoclonal Antibodies (Clone W6/32)
In Vivo Grade Recombinant Anti-human HLA-DR Monoclonal Antibodies (Clone L243)
In Vivo Grade Recombinant Anti-human HLA-DR/DP/DQ Monoclonal Antibodies (Clone F3.3)
In Vivo Grade Recombinant Anti-human HLA Class I Heavy Chain Monoclonal Antibodies (Clone HC10)
In Vivo Grade Recombinant Anti-human HLA class II DR/DQ Monoclonal Antibodies (Clone 9.3F10)
In Vivo Grade Recombinant Anti-human MHC Class II HLA-DP/DQ/DR Monoclonal Antibodies (Clone IVA12)
Recombinant Anti-human HLA-ABC Monoclonal Antibodies (Clone W6/32) for flow cytometry
Recombinant Anti-human HLA-DR Monoclonal Antibodies (Clone L243) for flow cytometry
Recombinant Anti-human HLA-DR/DP/DQ Monoclonal Antibodies (Clone F3.3) for flow cytometry
Recombinant Anti-human HLA Class I Heavy Chain Monoclonal Antibodies (Clone HC10) for flow cytometry
Recombinant Anti-human HLA class II DR/DQ Monoclonal Antibodies (Clone 9.3F10) for flow cytometry

Related Links

See our Privacy Policy